Federated Hermes’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.67K | Buy |
+2,655
| New | +$7.67K | ﹤0.01% | 1850 |
|
|
2024
Q4 | – | Sell |
-3
| Closed | -$20 | – | 2146 |
|
|
2024
Q3 | $20 | Buy |
3
+2
| +200% | +$13 | ﹤0.01% | 2037 |
|
|
2024
Q2 | $7 | Buy |
+1
| New | +$7 | ﹤0.01% | 2008 |
|
|
2020
Q2 | – | Sell |
-2
| Closed | -$1K | – | 2315 |
|
|
2020
Q1 | $1K | Sell |
2
-2
| -50% | -$1K | ﹤0.01% | 2121 |
|
|
2019
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 2113 |
|
|
2019
Q3 | $1K | Sell |
4
-5
| -56% | -$1.25K | ﹤0.01% | 2112 |
|
|
2019
Q2 | $1K | Sell |
9
-39
| -81% | -$4.33K | ﹤0.01% | 2114 |
|
|
2019
Q1 | $2K | Sell |
48
-159
| -77% | -$6.63K | ﹤0.01% | 2067 |
|
|
2018
Q4 | $12K | Sell |
207
-37
| -15% | -$2.15K | ﹤0.01% | 1848 |
|
|
2018
Q3 | $34K | Sell |
244
-3
| -1% | -$418 | ﹤0.01% | 1785 |
|
|
2018
Q2 | $30K | Sell |
247
-3,931
| -94% | -$477K | ﹤0.01% | 1748 |
|
|
2018
Q1 | $373K | Sell |
4,178
-3,020
| -42% | -$270K | ﹤0.01% | 1433 |
|
|
2017
Q4 | $399K | Sell |
7,198
-245
| -3% | -$13.6K | ﹤0.01% | 1413 |
|
|
2017
Q3 | $314K | Sell |
7,443
-3,326
| -31% | -$140K | ﹤0.01% | 1434 |
|
|
2017
Q2 | $454K | Buy |
10,769
+3
| +0% | +$126 | ﹤0.01% | 1394 |
|
|
2017
Q1 | $602K | Sell |
10,766
-39
| -0.4% | -$2.18K | ﹤0.01% | 1286 |
|
|
2016
Q4 | $412K | Buy |
10,805
+2,294
| +27% | +$87.5K | ﹤0.01% | 1357 |
|
|
2016
Q3 | $338K | Buy |
8,511
+1,446
| +20% | +$57.4K | ﹤0.01% | 1384 |
|
|
2016
Q2 | $508K | Buy |
7,065
+7,056
| +78,400% | +$507K | ﹤0.01% | 1272 |
|
|
2016
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 2027 |
|
|
2015
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 2017 |
|